However, MTHFR-rs1801131 polymorphism is significantly associated with a worst prognosis in homozygous mutated patients versus homozygous wild type patients (2.48 fold relative risk of death) rendering it a significant predictor for 5FU response in colorectal cancer patients [38,39]. This evidence concerns the gene MTHFR and colorectal cancer.